A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors

Clinical trial NCT07043751 · RECRUITING

Trial details

NCT number: NCT07043751
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2025-07-15
Primary completion: 2027-12-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.